UBS Initiates Coverage On Core Scientific with Buy Rating, Announces Price Target of $24

UBS analyst Ryan Gravett has initiated coverage on Core Scientific (NASDAQ: CORZ) with a Buy rating. The firm has set a price target of $24 for the company's stock.